On 14 September 2026, BANK OF GANSU (02139.HK) announced that, at the board meeting held on the same date, the Board resolved to propose the appointment of Mr. Du Jing as an executive director of the fourth session of the board of directors of the Bank and agreed to appoint him as president of the Bank; both his director and president qualifications are subject to approval by the Gansu Regulatory Bureau of the National Financial Regulatory Administration.
On 14 September 2026, MAOYE INT'L (00848.HK) announced that, in order to devote more time to her personal affairs, Ms. Lu Xiaojuan has resigned as an executive Director of the Company on the same date and will continue to serve as the chief financial officer of the Company.
On 14 September 2026, MAXICITY (02295.HK) announced that, in order to restore the Company's public float, as at 10 September 2026 the Offeror, GreenAir Energy Global Limited, had disposed of a total of 33,980,000 Offer Shares to independent third parties through a placing, representing approximately 8.50% of the total number of issued Shares; immediately after the Placing and as at the date of the announcement, the total number of Shares held by the public was 100,000,000 Shares, representing 25% of the total number of issued Shares, and the minimum public float requirement of 25% under Rule 13.32B(1) of the Listing Rules has been restored.
on September 14, 2026, the three major Hong Kong indices moved mixed, with the Hang Seng Index up 0.45%, the Hang Seng TECH Index down slightly by 0.06%, and the Hang Seng China Enterprises Index up 0.46%. The full-day market turnover was 192.6 billion HKD, Southbound funds saw a net inflow of 4.471 billion HKD.
On 14 September 2026, CR HOLDINGS (01911.HK) announced that China Renaissance Pan Asia Investment Advisory (Beijing) Co., Ltd., an indirect wholly-owned subsidiary of the Company, acted as sole financial adviser to the latest Series B financing of AlphaPai, an artificial intelligence application focused on financial scenarios.
On 14 September 2026, VISION VALUES (00862.HK) issued a profit warning stating that the Group is expected to record a loss attributable to owners of the Company of approximately HKD 437,000,000 to HKD 440,000,000 for the year ended 30 June 2026, compared with a net loss of approximately HKD 56,200,000 for the year ended 30 June 2025.
As of 15:30 on September 14, Global X S&P Crude Oil ETF (03097.HK) rose 1.19% to HKD 10.200, with a turnover of approximately HKD 3.5261 million and assets under management of approximately HKD 120 million.
on 14 September 2026, AI chip stocks traded with volatility while HUA HONG GRACE (01347.HK) weakened. As of 13:58, the company quoted HKD 107.200, down 4.03%.
on 14 September 2026, humanoid robot stocks traded with volatility while XIAOMI-W (01810.HK) strengthened. As of 13:24, the company quoted HKD 27.020, up 2.50%.
The three major Hong Kong stock indices weakened throughout the week of September 7–11, 2026, with the Hang Seng Index down 3.30%, the Hang Seng TECH Index down 5.45% and the Hang Seng China Enterprises Index down 3.61%. while average daily turnover was about HKD 209.6 billion and southbound net buying totalled about HKD 20.1 billion. The Stock Connect eligible securities list adjustment took effect on September 7, with 54 stocks added and 15 removed, and BIDU-W was formally included in Stock Connect, with Citi expecting it to attract about USD 6 billion (about HKD 47 billion) in net new southbound capital over the next 2 to 4 months.
On 14 September 2026, ADICON HOLDINGS (09860.HK) published its 2026 interim report, with revenue of RMB 1,284.8 million for the six months ended 30 June 2026, up 1.1% year on year; gross profit of RMB 487.1 million, up 7.2%, at a 37.9% gross margin; profit for the period of RMB 35.3 million, up 23.4%, of which RMB 32.0 million was attributable to owners of the parent, with basic earnings per share of RMB 0.04; cash and cash equivalents of RMB 870.9 million as at 30 June 2026; and no interim dividend declared.
On 14 September 2026, JINCHUAN INTL (02362.HK) published its 2026 interim report, with revenue of USD 460.2 million for the six months ended 30 June 2026, up 152% year on year; gross profit of USD 167.5 million, profit for the period of USD 61.0 million and profit attributable to shareholders of USD 47.8 million; 36,083 tonnes of copper and 349 tonnes of cobalt sold during the period; bank balances and cash of USD 257.4 million and a gearing ratio of 41.3% as at 30 June 2026; and no interim dividend declared.
On 14 September 2026, IMPACT THERAP-B (07630.HK) published its 2026 interim report, with revenue of RMB 105.2 million for the six months ended 30 June 2026, up 316.8% year on year, including Senaparib sales in China of RMB 70.4 million, up 877.8%; gross profit of RMB 95.5 million at a 90.8% gross margin; loss of RMB 90.8 million, narrowing 29.5%, and adjusted net loss of RMB 20.9 million, narrowing 62.6%; cash and financial assets totalled RMB 1,065.4 million as at 30 June 2026, and no interim dividend was declared.
On 14 September 2026, INSILICO (03696.HK) announced that Mr. Zavoronkovs, chairman of the Board, executive director, chief executive officer and single largest shareholder of the Company, acquired 113,500 ordinary shares in on-market transactions with his personal funds during the period from 4 to 7 September 2026, and is entitled to exercise voting rights over 46,757,000 shares, or approximately 8.02% of the total issued share capital, immediately following the purchase; the purchase was the first tranche under the shareholding increase plan announced on 4 September 2026.
On 14 September 2026, 160 HEALTH (02656.HK) announced in a voluntary announcement that its domestic subsidiary had completed the delivery of an integrated solution in a total amount of RMB 12.2 million to a big health enterprise focusing on the research and development of smart wearable health devices, and had obtained an acceptance certificate, with the solution comprising a smart health monitoring system, computing power infrastructure and integrated commissioning services; the announcement cautioned that the business remains at an early stage and has not yet formed a scaled or recurring revenue model, and that the order is not a discloseable transaction under Chapter 14 or a connected transaction under Chapter 14A of the Listing Rules.
On 14 September 2026, FORMS SYNTRON (06700.HK) published a prospectus to launch its global offering of H shares at a maximum offer price of HKD 16.00 per H share, comprising 58,961,100 H shares, of which 5,896,200 H shares are under the Hong Kong offering and 53,064,900 H shares under the international offering; based on the maximum offer price, net proceeds after underwriting fees and estimated expenses are estimated at approximately HKD 869.4 million. The offer price is expected to be determined on or around 18 September 2026, and the H shares are expected to commence trading on the Stock Exchange at 9:00 a.m. on 22 September 2026.
